Annual Operating Profit
-$45.26 M
-$1.64 M-3.76%
December 31, 2023
Summary
- As of February 26, 2025, HEPA annual operating income is -$45.26 million, with the most recent change of -$1.64 million (-3.76%) on December 31, 2023.
- During the last 3 years, HEPA annual operating profit has fallen by -$25.11 million (-124.65%).
- HEPA annual operating profit is now -2606.66% below its all-time high of -$1.67 million, reached on June 30, 2014.
Performance
HEPA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$4.46 M
+$4.05 M+47.57%
September 30, 2024
Summary
- As of February 26, 2025, HEPA quarterly operating income is -$4.46 million, with the most recent change of +$4.05 million (+47.57%) on September 30, 2024.
- Over the past year, HEPA quarterly operating profit has increased by +$6.21 million (+58.20%).
- HEPA quarterly operating profit is now -2630.13% below its all-time high of -$163.30 thousand, reached on December 31, 2013.
Performance
HEPA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$25.36 M
+$6.21 M+19.66%
September 30, 2024
Summary
- As of February 26, 2025, HEPA TTM operating income is -$25.36 million, with the most recent change of +$6.21 million (+19.66%) on September 30, 2024.
- Over the past year, HEPA TTM operating profit has increased by +$22.45 million (+46.95%).
- HEPA TTM operating profit is now -13959.31% below its all-time high of -$180.40 thousand, reached on September 30, 2013.
Performance
HEPA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
HEPA Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.8% | +58.2% | +47.0% |
| 3 y3 years | -124.7% | +50.5% | +16.6% |
| 5 y5 years | -210.1% | +50.5% | +16.6% |
HEPA Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -48.9% | at low | at high | +75.4% | at high | +48.8% |
| 5 y | 5-year | -482.5% | at low | -98.8% | +75.4% | -226.4% | +48.8% |
| alltime | all time | -2606.7% | at low | -2630.1% | +75.4% | <-9999.0% | +48.8% |
Hepion Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.46 M(-47.6%) | -$25.36 M(-19.7%) |
| Jun 2024 | - | -$8.50 M(+64.1%) | -$31.57 M(-15.2%) |
| Mar 2024 | - | -$5.18 M(-28.2%) | -$37.23 M(-17.7%) |
| Dec 2023 | -$45.26 M(+3.8%) | -$7.22 M(-32.3%) | -$45.26 M(-5.3%) |
| Sep 2023 | - | -$10.66 M(-24.7%) | -$47.81 M(+4.8%) |
| Jun 2023 | - | -$14.17 M(+7.2%) | -$45.61 M(-8.0%) |
| Mar 2023 | - | -$13.21 M(+35.2%) | -$49.57 M(+13.7%) |
| Dec 2022 | -$43.62 M(+43.5%) | -$9.77 M(+15.4%) | -$43.62 M(+1.8%) |
| Sep 2022 | - | -$8.47 M(-53.3%) | -$42.84 M(-0.1%) |
| Jun 2022 | - | -$18.13 M(+149.9%) | -$42.90 M(+35.6%) |
| Mar 2022 | - | -$7.25 M(-19.4%) | -$31.62 M(+4.0%) |
| Dec 2021 | -$30.40 M(+50.9%) | -$9.00 M(+5.7%) | -$30.40 M(+15.4%) |
| Sep 2021 | - | -$8.52 M(+24.3%) | -$26.36 M(+9.5%) |
| Jun 2021 | - | -$6.85 M(+13.6%) | -$24.07 M(+9.5%) |
| Mar 2021 | - | -$6.03 M(+21.8%) | -$21.99 M(+9.2%) |
| Dec 2020 | -$20.15 M(+159.3%) | -$4.95 M(-20.5%) | -$20.15 M(+15.5%) |
| Sep 2020 | - | -$6.23 M(+30.5%) | -$17.44 M(+32.9%) |
| Jun 2020 | - | -$4.78 M(+14.1%) | -$13.12 M(+30.7%) |
| Mar 2020 | - | -$4.19 M(+86.7%) | -$10.04 M(+29.2%) |
| Dec 2019 | -$7.77 M | -$2.24 M(+17.4%) | -$7.77 M(-8.8%) |
| Sep 2019 | - | -$1.91 M(+12.7%) | -$8.52 M(-18.6%) |
| Jun 2019 | - | -$1.70 M(-11.8%) | -$10.47 M(-17.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$1.92 M(-35.8%) | -$12.65 M(-13.3%) |
| Dec 2018 | -$14.59 M(+38.7%) | -$3.00 M(-22.2%) | -$14.59 M(+25.8%) |
| Sep 2018 | - | -$3.85 M(-0.8%) | -$11.60 M(-14.6%) |
| Jun 2018 | - | -$3.88 M(+0.6%) | -$13.58 M(-8.9%) |
| Mar 2018 | - | -$3.86 M(-33.9%) | -$14.92 M(-32.2%) |
| Dec 2017 | -$10.52 M(-50.0%) | - | - |
| Sep 2017 | - | -$5.84 M(+11.9%) | -$21.99 M(+4.6%) |
| Jun 2017 | -$21.02 M(+1.0%) | -$5.22 M(+6.3%) | -$21.02 M(-2.7%) |
| Mar 2017 | - | -$4.91 M(-18.5%) | -$21.60 M(+1.2%) |
| Dec 2016 | - | -$6.02 M(+23.5%) | -$21.35 M(+2.4%) |
| Sep 2016 | - | -$4.88 M(-15.8%) | -$20.84 M(+0.2%) |
| Jun 2016 | -$20.81 M(+49.0%) | -$5.79 M(+24.5%) | -$20.81 M(+2.1%) |
| Mar 2016 | - | -$4.65 M(-15.6%) | -$20.39 M(+1.3%) |
| Dec 2015 | - | -$5.51 M(+13.8%) | -$20.13 M(+13.6%) |
| Sep 2015 | - | -$4.84 M(-9.9%) | -$17.72 M(+26.9%) |
| Jun 2015 | -$13.96 M(+734.9%) | -$5.38 M(+22.2%) | -$13.96 M(+47.7%) |
| Mar 2015 | - | -$4.40 M(+41.7%) | -$9.45 M(+71.4%) |
| Dec 2014 | - | -$3.10 M(+186.8%) | -$5.52 M(+114.2%) |
| Sep 2014 | - | -$1.08 M(+24.5%) | -$2.57 M(+53.9%) |
| Jun 2014 | -$1.67 M | -$869.50 K(+89.4%) | -$1.67 M(+108.3%) |
| Mar 2014 | - | -$459.00 K(+181.1%) | -$802.70 K(+133.5%) |
| Dec 2013 | - | -$163.30 K(-9.5%) | -$343.70 K(+90.5%) |
| Sep 2013 | - | -$180.40 K | -$180.40 K |
FAQ
- What is Hepion Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals annual operating profit year-on-year change?
- What is Hepion Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals quarterly operating profit year-on-year change?
- What is Hepion Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals TTM operating profit year-on-year change?
What is Hepion Pharmaceuticals annual operating income?
The current annual operating profit of HEPA is -$45.26 M
What is the all time high annual operating profit for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high annual operating income is -$1.67 M
What is Hepion Pharmaceuticals annual operating profit year-on-year change?
Over the past year, HEPA annual operating income has changed by -$1.64 M (-3.76%)
What is Hepion Pharmaceuticals quarterly operating income?
The current quarterly operating profit of HEPA is -$4.46 M
What is the all time high quarterly operating profit for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high quarterly operating income is -$163.30 K
What is Hepion Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, HEPA quarterly operating income has changed by +$6.21 M (+58.20%)
What is Hepion Pharmaceuticals TTM operating income?
The current TTM operating profit of HEPA is -$25.36 M
What is the all time high TTM operating profit for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high TTM operating income is -$180.40 K
What is Hepion Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, HEPA TTM operating income has changed by +$22.45 M (+46.95%)